• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脐血移植的急性白血病患者生存预测的综合评分系统。

An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.

机构信息

Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Israel.

Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Israel.

出版信息

Clin Cancer Res. 2017 Nov 1;23(21):6478-6486. doi: 10.1158/1078-0432.CCR-17-0489. Epub 2017 Jul 28.

DOI:10.1158/1078-0432.CCR-17-0489
PMID:28754820
Abstract

Survival of acute leukemia (AL) patients following umbilical cord blood transplantation (UCBT) is dependent on an array of individual features. Integrative models for risk assessment are lacking. We sought to develop a scoring system for prediction of overall survival (OS) and leukemia-free survival (LFS) at 2 years following UCBT in AL patients. The study cohort included 3,140 pediatric and adult AL UCBT patients from the European Society of Blood and Marrow Transplantation and Eurocord registries. Patients received single or double cord blood units. The dataset was geographically split into a derivation ( = 2,362, 65%) and validation set ( = 778, 35%). Top predictors of OS were identified using the Random Survival Forest algorithm and introduced into a Cox regression model, which served for the construction of the UCBT risk score. The score includes nine variables: disease status, diagnosis, cell dose, age, center experience, cytomegalovirus serostatus, degree of HLA mismatch, previous autograft, and anti-thymocyte globulin administration. Over the validation set an increasing score was associated with decreasing probabilities for 2 years OS and LFS, ranging from 70.21% [68.89-70.71, 95% confidence interval (CI)] and 64.76% (64.33-65.86, 95% CI) to 14.78% (10.91-17.41) and 18.11% (14.40-22.30), respectively. It stratified patients into six distinct risk groups. The score's discrimination (AUC) over multiple imputations of the validation set was 68.76 (68.19-69.04, range) and 65.78 (65.20-66.28) for 2 years OS and LFS, respectively. The UCBT score is a simple tool for risk stratification of AL patients undergoing UCBT. Widespread application of the score will require further independent validation. .

摘要

急性白血病(AL)患者在接受脐带血移植(UCBT)后的生存取决于一系列个体特征。目前缺乏综合的风险评估模型。我们旨在为 AL 患者在 UCBT 后 2 年的总生存(OS)和无白血病生存(LFS)建立预测评分系统。该研究队列包括来自欧洲血液和骨髓移植协会和欧洲 cord 注册中心的 3140 名儿科和成人 AL UCBT 患者。患者接受了单份或双份脐带血单位。数据集在地理上分为推导集(=2362,65%)和验证集(=778,35%)。使用随机生存森林算法确定 OS 的主要预测因素,并将其引入 Cox 回归模型,用于构建 UCBT 风险评分。该评分包括 9 个变量:疾病状态、诊断、细胞剂量、年龄、中心经验、巨细胞病毒血清状态、HLA 错配程度、既往自体移植和抗胸腺细胞球蛋白的使用。在验证集中,评分越高,2 年 OS 和 LFS 的概率越低,从 70.21%(68.89-70.71,95%置信区间[CI])和 64.76%(64.33-65.86,95%CI)到 14.78%(10.91-17.41)和 18.11%(14.40-22.30)。它将患者分为六个不同的风险组。该评分在验证集的多个插补中的区分度(AUC)为 68.76(68.19-69.04,范围)和 65.78(65.20-66.28),分别用于 2 年 OS 和 LFS。UCBT 评分是一种用于接受 UCBT 的 AL 患者风险分层的简单工具。该评分的广泛应用需要进一步的独立验证。

相似文献

1
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.基于脐血移植的急性白血病患者生存预测的综合评分系统。
Clin Cancer Res. 2017 Nov 1;23(21):6478-6486. doi: 10.1158/1078-0432.CCR-17-0489. Epub 2017 Jul 28.
2
Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.在中国进行的一项回顾性研究中,与无关供者外周血干细胞移植治疗急性白血病相比,不使用抗胸腺细胞球蛋白的脐带血移植生存率相似,但生活质量更佳。
Biol Blood Marrow Transplant. 2017 Sep;23(9):1541-1548. doi: 10.1016/j.bbmt.2017.05.004. Epub 2017 May 9.
3
Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia.清髓性无关脐带血移植治疗青少年和年轻成人急性白血病。
Biol Blood Marrow Transplant. 2019 Dec;25(12):2438-2446. doi: 10.1016/j.bbmt.2019.07.031. Epub 2019 Aug 5.
4
Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.血液系统恶性肿瘤患者接受无关供者脐带血移植与骨髓或外周血造血干细胞移植的疗效比较:单中心分析。
Chin Med J (Engl). 2013 Jul;126(13):2499-503.
5
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.无关供者脐带血移植治疗骨髓增生异常综合征或继发性急性髓系白血病成人患者:欧洲血液和骨髓移植学会脐带血移植工作组和欧洲白血病网调查
Leukemia. 2011 Jan;25(1):75-81. doi: 10.1038/leu.2010.219. Epub 2010 Sep 30.
6
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia.急性髓细胞白血病自体干细胞移植后无白血病生存的个体化预测。
Cancer. 2019 Oct 15;125(20):3566-3573. doi: 10.1002/cncr.32344. Epub 2019 Jun 21.
7
Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.异基因无关脐血移植治疗儿童噬血细胞性淋巴组织细胞增生症的持久嵌合状态和长期生存:单中心经验。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1722-1728. doi: 10.1016/j.bbmt.2017.06.013. Epub 2017 Jun 21.
8
European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation.欧洲血液和骨髓移植学会风险评分可预测急性白血病患者接受单份脐带血移植的结局。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2118-2126. doi: 10.1016/j.bbmt.2017.08.011. Epub 2017 Aug 12.
9
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.评估接受脐带血移植治疗血液系统恶性肿瘤的成年患者的疾病风险指数。
Br J Haematol. 2017 Dec;179(5):790-801. doi: 10.1111/bjh.14962. Epub 2017 Oct 19.
10
Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis.缓解期儿童急性淋巴细胞白血病接受脐血移植后微小残留病的影响:Eurocord、PDWP-EBMT 分析。
Leukemia. 2012 Dec;26(12):2455-61. doi: 10.1038/leu.2012.123. Epub 2012 May 4.

引用本文的文献

1
Unrelated cord blood as a source of stem cells: cryopreservation damage can be alleviated by restoring mitochondrial function.无关供者脐血作为干细胞来源:恢复线粒体功能可减轻冷冻保存损伤。
Blood Sci. 2025 Jun 25;7(3):e00243. doi: 10.1097/BS9.0000000000000243. eCollection 2025 Sep.
2
The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia.中心经验对急性髓细胞白血病异基因造血细胞移植结局的影响。
Bone Marrow Transplant. 2024 Apr;59(4):541-549. doi: 10.1038/s41409-024-02222-5. Epub 2024 Feb 6.
3
Limited Contribution of Donor Characteristics to One-Year Survival After Hematopoietic Stem Cell Transplantation.
供者特征对造血干细胞移植后 1 年存活率的影响有限。
Transplant Cell Ther. 2022 Dec;28(12):843.e1-843.e6. doi: 10.1016/j.jtct.2022.08.022. Epub 2022 Aug 28.
4
Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia.成人急性髓系白血病患者行单份脐带血移植后生存和植入情况的改善趋势。
Blood Cancer J. 2022 May 25;12(5):81. doi: 10.1038/s41408-022-00678-6.
5
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012.中心经验对供者类型影响的研究:一项二次分析,血液和骨髓移植临床研究网络 1101 于 2012 年 6 月开始入组,2012 年 6 月开始入组。
Transplant Cell Ther. 2022 Jul;28(7):406.e1-406.e6. doi: 10.1016/j.jtct.2022.03.024. Epub 2022 Apr 4.
6
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning.基于集成学习的异基因 HSCT 后无 GVHD 无复发生存的预测模型的建立。
Blood Adv. 2022 Apr 26;6(8):2618-2627. doi: 10.1182/bloodadvances.2021005800.
7
The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations.移植物抗宿主病对欧洲和日本人群成人单份脐血移植后结局的影响。
Bone Marrow Transplant. 2022 Jan;57(1):57-64. doi: 10.1038/s41409-021-01479-4. Epub 2021 Oct 11.
8
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.双份脐血移植联合未经抗胸腺细胞球蛋白的单倍体相合 CD34+细胞后的植入动力学。
Leukemia. 2021 Mar;35(3):850-862. doi: 10.1038/s41375-020-0922-x. Epub 2020 Jun 18.
9
Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy.决策分析模型作为一种工具,用于为合并造血干细胞移植的血液系统恶性肿瘤患者选择最佳治疗方案。
Bone Marrow Transplant. 2020 Jul;55(7):1220-1228. doi: 10.1038/s41409-020-0784-x. Epub 2020 Jan 13.
10
Assessing the risk of early unplanned rehospitalisation in preterm babies: EPIPAGE 2 study.评估早产儿早期非计划性再入院风险:EPIPAGE 2 研究。
BMC Pediatr. 2019 Nov 21;19(1):451. doi: 10.1186/s12887-019-1827-6.